" /> Adenoviral Vector Ad5-CEA(6D) Vaccine - CISMeF





Preferred Label : Adenoviral Vector Ad5-CEA(6D) Vaccine;

NCIt synonyms : Ad5 CEA Vaccine;

NCIt related terms : ETBX-011;

NCIt definition : A replication-defective, E1- and E2b-deleted oncolytic adenoviral serotype 5 (Ad5) encoding an epitope of human carcinoembryonic antigen (CEA) with potential antineoplastic activity. Adenoviral vector Ad5-CEA(6D) vaccine expresses a highly immunogenic analogue of CEA [CAP1-(6D)]. Upon administration, this vaccine may induce both humoral and cellular immune responses against tumor cells expressing the CEA antigen, thereby resulting in the immune-mediated inhibition of tumor cell proliferation and tumor cell death. CEA, a tumor-associated antigen, is overexpressed in various tumor cell types. Deletion of early genes E1 and E2b in Ad5 potentially circumvent pre-existing anti-adenovirus immunity and is capable of inducing strong immune responses.;

UNII : RP9RQ0SOM8;

CAS number : 2035095-05-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2035095-05-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : ETBX-011;

NCI Metathesaurus CUI : CL421635;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.